Genetic Basis of Cancer

Genetic Basis of Cancer

Genetic Basis of Cancer

On this page

Cancer Genes - The Prime Suspects

  • Proto-oncogenes (Accelerators):
    • Promote normal cell growth/division.
    • Mutation (gain-of-function) → Oncogenes (e.g., RAS, MYC, EGFR).
  • Tumor Suppressor Genes (TSGs) (Brakes):
    • Inhibit proliferation, induce apoptosis.
    • Mutation (loss-of-function, Knudson's "two-hit" hypothesis).
    • E.g., TP53, RB1, APC, BRCA1/2.
  • Apoptosis Regulating Genes:
    • Control programmed cell death.
    • Imbalance (e.g., ↑BCL-2 anti-apoptotic, ↓BAX pro-apoptotic) → uncontrolled cell survival.
  • DNA Repair Genes (Caretakers):
    • Maintain genomic integrity.
    • Defects → ↑mutation rates, genomic instability (e.g., MSH2, MLH1, BRCA).

⭐ TP53, "guardian of the genome," is the most commonly mutated gene, found in >50% of sporadic human cancers.

Oncogenes - Pedal to Metal

  • Mutated or overexpressed versions of normal proto-oncogenes; they drive uncontrolled cell proliferation via gain-of-function mutations.
  • Dominant: one mutated allele sufficient.
  • Activation Mechanisms:
    • Point Mutation: RAS (pancreatic, colon, lung Ca).
    • Gene Amplification: N-MYC (neuroblastoma), ERBB2/HER2 (breast Ca).
    • Chromosomal Translocation:
      • BCR-ABL (t(9;22), Philadelphia chr.): CML.
      • MYC (t(8;14)): Burkitt lymphoma.
  • Examples & Roles:
    • RAS: GTP-binding protein, signal transduction.
    • MYC: Transcription factor, cell cycle progression.
    • ERBB2 (HER2): Receptor tyrosine kinase.
    • ABL: Non-receptor tyrosine kinase.

⭐ BCR-ABL fusion in CML results in constitutively active tyrosine kinase, a prime target for imatinib.

Tumor Suppressors - Guardians Down!

  • Act as cellular "brakes"; normally prevent uncontrolled cell growth.
  • Loss-of-function mutations promote cancer.
  • Typically require inactivation of both alleles (Knudson's "two-hit" hypothesis).
    • First hit: often germline (inherited).
    • Second hit: somatic (acquired).
  • Key Examples & Associations:
    • RB1: Retinoblastoma, osteosarcoma (G1/S checkpoint).
    • TP53: Li-Fraumeni syndrome ("Guardian of the Genome").
    • APC: Familial adenomatous polyposis (FAP), colorectal cancer.
    • BRCA1/BRCA2: Hereditary breast and ovarian cancer.
    • NF1/NF2: Neurofibromatosis 1 & 2.
    • WT1: Wilms tumor.

⭐ TP53 is the most frequently mutated gene in human cancers, implicated in over 50% of sporadic tumors.

System Sabotage - Repair, Death, Epigenetics

  • DNA Repair Defects (Genomic Instability):
    • Mismatch Repair (MMR): HNPCC/Lynch (MSH2, MLH1). Microsatellite Instability (MSI).
    • Nucleotide Excision Repair (NER): Xeroderma Pigmentosum (XP). UV sensitivity, skin cancers.
    • Homologous Recombination (HR): BRCA1/2 mutations. Breast, ovarian cancer risk. Fanconi Anemia.
    • ATM gene: Ataxia-Telangiectasia. Defective DNA damage sensing.
  • Evasion of Apoptosis (Resisting Cell Death):
    • BCL-2 family: ↑Anti-apoptotic BCL-2 (follicular lymphoma t(14;18)).
    • TP53 mutations: Loss of p53-mediated apoptosis.
    • IAPs: Upregulation blocks caspases.
  • Epigenetic Alterations (Gene expression changes without DNA sequence alteration):
    • DNA Methylation: TSG promoter hypermethylation (CDKN2A, MLH1). Global hypomethylation.
    • Histone Modification: Altered acetylation, methylation (EZH2).
    • Non-coding RNAs: Dysregulated miRNAs (oncomiRs) & lncRNAs.

⭐ Follicular Lymphoma's t(14;18) translocation constitutively activates BCL-2 by placing it near the IgH enhancer, promoting cell survival via apoptosis evasion.

High‑Yield Points - ⚡ Biggest Takeaways

  • Proto-oncogenes (e.g., RAS, MYC) drive cancer via gain-of-function mutations.
  • Tumor suppressor genes (e.g., TP53, RB1) require loss-of-function (Knudson's two-hit hypothesis).
  • TP53 is the most commonly mutated gene in human cancers, crucial for cell cycle control.
  • Defects in DNA repair genes (e.g., BRCA1/2, MSH/MLH) lead to ↑ genomic instability.
  • Epigenetic alterations like hypermethylation can silence tumor suppressor genes.
  • Chromosomal translocations (e.g., BCR-ABL in CML) create oncogenic fusion proteins.
  • Telomerase reactivation allows limitless replicative potential, a hallmark of cancer.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Genetic Basis of Cancer

  1. 1. An 8-year-old boy has recurrent painful episodes since early childhood, with icterus and splenomegaly on examination. Before any transfusion, MCV is 65 fL and hemoglobin analysis shows HbS 70%, HbA 20%, HbA2 6% and HbF 4%. What is the most likely diagnosis?

    • A. Hemoglobin C disease
    • B. Sickle cell trait
    • C. Sickle cell anemia
    • D. Sickle β-thalassemia
    Show answer

    Answer: D. Sickle β-thalassemia

    Sickle β-thalassemia is a form of sickle cell disease and is supported by HbS predominance, microcytosis, elevated HbA2 and retained HbA before transfusion, indicating the beta-plus form. Sickle cell trait usually shows HbA predominance and does not ordinarily cause recurrent vaso-occlusive episodes. Hemoglobin C disease produces predominantly HbC rather than HbS. Sickle cell anemia does not produce HbA before transfusion, although HbA2 measurements can overlap with those in sickle beta thalassemia.

  2. 2. Which growth factor classically suppresses proliferation in normal epithelial cells?

    • A. PDGF
    • B. FGF
    • C. TGF-α
    • D. TGF-β
    Show answer

    Answer: D. TGF-β

    TGF-β - TGF-β is primarily growth inhibitory, suppressing cell proliferation and promoting differentiation or apoptosis in many normal cells. - It is the exception because, unlike the other listed growth factors, its principal effect is antiproliferative, although its effects can vary during tumor progression. TGF-α - TGF-α stimulates cell proliferation by binding the EGF receptor, promoting growth and contributing to tumor development. - As a growth-promoting factor, TGF-α does not fit the exception; it supports proliferative signaling rather than primarily inhibiting cell division. PDGF - PDGF is a potent mitogen for connective-tissue cells and promotes proliferation and migration. - Its roles in wound healing and tumor growth identify it as a growth-promoting factor, so it is not the exception. FGF - FGF promotes mitosis and supports proliferation in several cell types during development and tissue repair. - FGF also contributes to angiogenesis and is overexpressed in some tumors, making it a growth-promoting factor rather than the exception.

  3. 3. A 30-year-old woman has fever and recurrent haemoptysis for 2 weeks. Histology of a resected pulmonary mass is shown below. What is the diagnosis?

    • A. Pulmonary adenocarcinoma
    • B. Large cell carcinoma
    • C. Carcinoid tumour
    • D. Pulmonary hamartoma
    Show answer

    Answer: C. Carcinoid tumour

    Carcinoid tumour is supported by the relatively uniform cells arranged in nests and short trabeculae with granular nuclear chromatin in the pulmonary section. Pulmonary hamartoma would show benign mesenchymal components, often cartilage or fat, with entrapped respiratory epithelium. Pulmonary adenocarcinoma would show malignant gland formation or mucinous differentiation rather than this organoid neuroendocrine pattern. Large cell carcinoma would show an undifferentiated malignant population with greater cytological atypia rather than these relatively uniform organized nests.

  4. 4. Which tumour-suppressor gene is most commonly implicated in familial malignant melanoma predisposition?

    • A. BAP1 (3p21.1)
    • B. CDKN2A (9p21)
    • C. PTEN (10q23.31)
    • D. TP53 (17p13.1)
    Show answer

    Answer: B. CDKN2A (9p21)

    CDKN2A (9p21) is the most commonly implicated tumour-suppressor gene in familial melanoma predisposition; its products include p16INK4A and p14ARF. BAP1 (3p21.1) causes a less common tumour-predisposition syndrome that can include uveal and cutaneous melanoma. PTEN (10q23.31) is associated with PTEN hamartoma tumour syndrome, not the principal familial melanoma predisposition. TP53 (17p13.1) causes Li–Fraumeni syndrome, not the most common inherited melanoma predisposition.

  5. 5. N-myc amplification is routinely used for risk stratification in which childhood tumor?

    • A. Neuroblastoma
    • B. Retinoblastoma
    • C. Rhabdomyosarcoma
    • D. Nephroblastoma
    Show answer

    Answer: A. Neuroblastoma

    Neuroblastoma - N-MYC amplification is an important prognostic marker in neuroblastoma, indicating biologically aggressive disease and poorer outcomes. - Neuroblastoma is a neural crest tumor of childhood, commonly arising in the adrenal medulla or sympathetic ganglia, where N-MYC status helps guide prognosis. Retinoblastoma - Retinoblastoma prognosis depends chiefly on disease extent and high-risk pathological features such as optic-nerve or massive choroidal invasion, whereas RB1 inactivation is its usual initiating alteration. - This is a childhood retinal tumor, so its characteristic molecular association is RB1 inactivation, not the N-MYC prognostic feature described for neuroblastoma. Rhabdomyosarcoma - Rhabdomyosarcoma prognosis depends on clinical stage, histologic subtype, and alterations such as PAX3/7-FOXO1, rather than N-MYC amplification. - This is a soft-tissue sarcoma with skeletal muscle differentiation; its common prognostic molecular findings do not identify it as the tumor in the question. Nephroblastoma - Nephroblastoma prognosis depends on stage and histology, particularly diffuse anaplasia; combined 1p/16q loss is an established adverse molecular marker. - This is a childhood renal tumor, whereas N-MYC amplification is the characteristic prognostic marker emphasized for neuroblastoma.

  6. 6. Which of the following conditions is least associated with tumor suppressor genes?

    • A. Retinoblastoma
    • B. Hereditary breast cancer
    • C. Neurofibromatosis
    • D. Acute myeloid leukemia
    Show answer

    Answer: D. Acute myeloid leukemia

    Acute myeloid leukemia is least classically associated with tumor-suppressor gene defects among these conditions. Its pathogenesis commonly involves acquired alterations in signaling and transcription, although tumor-suppressor abnormalities can occur. Retinoblastoma is classically associated with inactivation of the RB1 tumor suppressor gene. Hereditary breast cancer has recognized associations with the BRCA1 and BRCA2 tumor suppressor genes, which participate in DNA repair. Neurofibromatosis involves defects in the NF1 or NF2 tumor suppressor genes. These established tumor-suppressor associations make the other conditions less suitable answers.

  7. 7. Which coagulation test is most appropriate for preoperative assessment of a patient with vitamin K deficiency?

    • A. Prothrombin time
    • B. Bleeding time
    • C. Whole-blood clotting time
    • D. Activated partial thromboplastin time
    Show answer

    Answer: A. Prothrombin time

    Prothrombin time - Vitamin K enables gamma-carboxylation of factors II, VII, IX, and X; factor VII has the shortest half-life, making prothrombin time the earliest sensitive abnormality. - Prothrombin time assesses the extrinsic and common pathways, including factor VII, and is therefore the appropriate preoperative test to identify increased bleeding risk in vitamin K deficiency. Bleeding time - Bleeding time evaluates platelet function and vascular integrity, whereas vitamin K deficiency primarily affects circulating coagulation factors. - Because platelet plug formation is generally preserved, bleeding time is usually normal and does not assess the principal coagulation defect. Whole-blood clotting time - Whole-blood clotting time is an archaic, nonspecific bedside test and is less sensitive and standardized than prothrombin time for detecting vitamin K deficiency. - Although whole-blood clotting time may become prolonged in severe factor deficiency, it is not the preferred test for preoperative assessment. Activated partial thromboplastin time - Activated partial thromboplastin time can become prolonged in more severe vitamin K deficiency, but prothrombin time becomes abnormal earlier because factor VII has the shortest half-life.

  8. 8. A 15-year-old boy has biopsy-confirmed osteosarcoma. His mother developed breast cancer at 32 years and his maternal grandmother at 38 years. Which additional cancer is characteristically associated with the inherited predisposition suggested by this family history?

    • A. Brain glioma
    • B. Wilms tumor
    • C. Neuroblastoma
    • D. Hepatoblastoma
    Show answer

    Answer: A. Brain glioma

    Brain glioma is a characteristic brain tumor in Li-Fraumeni syndrome, suggested here by childhood osteosarcoma and breast cancer across successive maternal generations. Li-Fraumeni syndrome is usually caused by an autosomal dominant germline TP53 pathogenic variant. Wilms tumor is classically associated with WT1-related syndromes rather than this characteristic tumor combination. Neuroblastoma is not a core Li-Fraumeni tumor. Hepatoblastoma is more characteristically associated with Beckwith-Wiedemann syndrome or familial adenomatous polyposis.

  9. 9. What is the term for a localized malformation composed of an excessive but disorganized arrangement of cells and tissues indigenous to the site?

    • A. Teratoma
    • B. Choristoma
    • C. Hamartoma
    • D. Adenoma
    Show answer

    Answer: C. Hamartoma

    Hamartoma - A hamartoma is an excessive but disorganized proliferation of mature cells and tissues that are normally indigenous to the affected site. - It is generally a benign, tumor-like lesion, often congenital, and differs from a choristoma because the tissue remains in its appropriate location. Teratoma - Teratoma is a germ-cell neoplasm containing differentiated tissues from more than one germ layer. It is not defined by disorganised overgrowth of tissues indigenous to its site. Choristoma - A choristoma is composed of normal tissue located at an abnormal, heterotopic site, rather than tissue indigenous to the affected location. - The key distinction is location: choristoma means normal tissue in the wrong place, whereas hamartoma means locally appropriate tissue with disorganized architecture. Adenoma - Adenoma is a benign epithelial neoplasm, not a developmental overgrowth composed of disorganized tissues indigenous to the site.

  10. 10. The image below shows the life cycle of a virus. Which of the proteins of the virus act as oncogenes?

    • A. L1, L2
    • B. E1, E2, E5
    • C. E1, E2
    • D. E6, E7
    Show answer

    Answer: D. E6, E7

    E6, E7 - E6 promotes degradation of p53, removing a major checkpoint that normally induces cell-cycle arrest or apoptosis after cellular damage. - E7 inactivates pRb, releasing E2F-mediated cell-cycle progression and promoting uncontrolled proliferation and malignant transformation in high-risk HPV infection. E1, E2, E5 - E1 functions in viral DNA replication, while E2 regulates viral transcription and replication; these are essential for the viral life cycle rather than primary oncogenesis. - E5 may contribute to growth signaling in some HPV types, but it is less potent and less consistently oncogenic than E6 and E7. L1, L2 - L1 and L2 are late structural proteins that assemble the viral capsid, forming the outer shell of new HPV particles. - Although required for virion assembly, L1 and L2 do not primarily disrupt host tumor-suppressor pathways or drive malignant transformation. E1, E2 - E1 acts as a helicase and ATPase for viral DNA replication, while E2 regulates viral gene expression and replication. - These proteins support viral propagation but do not directly inactivate p53 or pRb, the key tumor-suppressor targets of HPV oncogenesis.

Flashcards: Genetic Basis of Cancer

  1. 1. ER/PR-_____, HER2-_____ cancers is the most common subtype of breast cancer in individuals who inherit germline mutations in BRCA2

    Show answer

    positive · negative

  2. 2. The tumor suppressors encoded by the CDKN2A gene enforce the G1-->S restriction point by:(1) - inhibiting CDK_____/_____ (2) - relieving inhibition of _____

    Show answer

    4 · 6 · P53

  3. 3. Loss of copies of a tumor suppressor gene (knudson two-hit hypothesis) arise from _____ (inherited) or _____ (sporadic) mutations

    Show answer

    germline · somatic

  4. 4. The KIT _____ encodes for the Stem Cell Factor receptor, which when bound leads to cell growth. This is a _____ found commonly in _____

    Show answer

    proto-oncogene · growth factor receptor · GI stromal tumor

  5. 5. Mutations that cause _____ of the PDGFB proto-oncogene can precipitate development of an Astrocytoma by creating an _____

    Show answer

    overexpression · autocrine loop

  6. 6. _____ is due to an inherited mutation in the _____ gene on chromosome _____

    Show answer

    Familial adenomatous polyposis (FAP) · APC · 5q

  7. 7. Wilms tumor is caused by "loss of function" mutations of tumor suppression genes _____ or _____ on chromosome _____

    Show answer

    WT1 · WT2 · 11

  8. 8. Lynch syndrome is associated with increased risk for _____, _____, _____, and skin cancers

    Show answer

    colorectal · endometrial · ovarian

  9. 9. The following image represents the _____ carcinoma subtype of invasive ductal carcinoma (breast): hint: the circled area is lymphatics

    Show answer

    inflammatory

  10. 10. In HPV-_____ SCC of the oral cavity, patients generally present with _____ primary lesions with variable nodal disease.

    Show answer

    negative · large

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF